Abstract
Age-related changes in the human hematopoietic system are subtle, are often difficult to separate from coexistent comorbidities, and are of clinical import under conditions that stress hematopoiesis. Anemia is the most common age-related hematologic abnormality, and in the elderly surgical patient, proper management of disorders of hemostasis and thrombosis is particularly important. These are covered in detail in the chapter that follows. Marrow disorders such as myelodysplasia (MDS), acute myeloid leukemia (AML), monoclonal gammopathies (MG), polycythemia vera (PV), essential thrombocythemia (ET), and idiopathic myelofibrosis (IMF), all of which have a predilection for the elderly, are also discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Chatta GS, Lipschitz DA (2008) Anemia. In: Hazzard W et al (eds) Principles of geriatric medicine and gerontology. McGraw-Hill, New York
Rossi DJ et al (2007) Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447(7145): 725–729
Corberand J et al (1981) Polymorphonuclear functions and aging in humans. J Am Geriatr Soc 29(9):391–397
Sasso RD, Hanna EA, Moore DL (1970) Leukocytic and neutrophilic counts in acute appendicitis. Am J Surg 120(5):563–566
Hodkinson CF et al (2006) Whole blood analysis of phagocytosis, apoptosis, cytokine production, and leukocyte subsets in healthy older men and women: the ZENITH study. J Gerontol A Biol Sci Med Sci 61(9):907–917
Plackett TP et al (2004) Aging and innate immune cells. J Leukoc Biol 76(2):291–299
Chatta GS et al (1994) Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 84(9):2923–2929
Smith TJ et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24(19):3187–3205
Eisenstaedt R, Penninx BW, Woodman RC (2006) Anemia in the elderly: current understanding and emerging concepts. Blood Rev 20(4):213–226
Spivak JL (2005) Anemia in the elderly: time for new blood in old vessels? Arch Intern Med 165(19):2187–2189
Ania BJ et al (1997) Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc 45(7):825–831
Guralnik JM et al (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104(8):2263–2268
Ferrucci L et al (2007) Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 136(6):849–855
Ferrucci L et al (2004) Circulating erythropoietin (EPO) and pro-inflammatory markers in elderly (>/=65) persons with and without anemia. Blood ASH Annu Meet Abstr 104:453a, Abstract 1629
Chatta G (2009) In: Geriatrics Review Syllabus (GRS), MKSAP
Clarke R et al (2004) Vitamin B12 and folate deficiency in later life. Age Ageing 33(1):34–41
Tefferi A, Vardiman JW (2009) Myelodysplastic syndromes. N Engl J Med 361(19):1872–1885
Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352(10):1011–1023
Drueke TB et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355(20):2071–2084
KDOQI; National Kidney Foundation (2006) KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47(5 Suppl 3):S11–S145
Lichtin A (2005) The ASH/ASCO clinical guidelines on the use of erythropoietin. Best Pract Res Clin Haematol 18(3):433–438
Renoult E et al (2006) Recurrent anemia in kidney transplant recipients with parvovirus B19 infection. Transplant Proc 38(7): 2321–2323
Estey E (2007) Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol 25(14):1908–1915
Mathew P et al (1993) The 5q- syndrome: a single-institution study of 43 consecutive patients. Blood 81(4):1040–1045
Kantarjian H et al (2006) Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 106(8):1794–1803
Silverman LR et al (2002) Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 20(10):2429–2440
List A et al (2006) Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 355(14):1456–1465
Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347(8):589–600
Levi M (2004) Current understanding of disseminated intravascular coagulation. Br J Haematol 124(5):567–576
Moake J (2009) Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Pract Res Clin Haematol 22(4):567–576
Zhan H et al (2010) Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse. Transfusion 50(4):868–874
Drews RE (2003) Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med 24(4):607–622
Mecozzi G et al (2002) Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg 123(3):550–556
Mari D et al (1995) Hypercoagulability in centenarians: the paradox of successful aging. Blood 85(11):3144–3149
Silverstein MD et al (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158(6):585–593
Kitchens C, Alving B (eds) (2007) Consultative hemostasis and thrombosis. Saunders/Elsevier, Philadelphia
Aster RH et al (2009) Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 7(6): 911–918
Warkentin TE (2007) Drug-induced immune-mediated thrombocytopenia – from purpura to thrombosis. N Engl J Med 356(9): 891–893
Slichter SJ (2007) Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program 172–178
Kapetanakis EI et al (2006) Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae? Circulation 113(13):1667–1674
Laux V et al (2009) Direct inhibitors of coagulation proteins – the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy? Thromb Haemost 102(5):892–899
Dispenzieri A, Kyle RA (2005) Multiple myeloma: clinical features and indications for therapy. Best Pract Res Clin Haematol 18(4):553–568
Kyle RA et al (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346(8):564–569
Stanworth SJ (2007) The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program 179–186
Franchini M (2006) Acquired hemophilia A. Hematology 11(2): 119–125
Rosendaal FR, VAN Hylckama Vlieg A, Doggen CJ (2007) Venous thrombosis in the elderly. J Thromb Haemost 5(Suppl 1):310–317
Blom JW et al (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4(3):529–535
Cushman M et al (2004) Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117(1):19–25
Zangari M et al (2001) Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 98(5):1614–1615
Warkentin TE (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121(4):535–555
Pouplard C et al (2007) Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 5(7):1373–1379
Devreese K, Peerlinck K, Hoylaerts MF (2010) Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood 115(4):870–878
Metjian A, Lim W (2009) ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Hematology Am Soc Hematol Educ Program 247–249
Geerts WH et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):381S–453S
Tefferi A (2008) Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy. Am J Hematol 83(6):491–497
Tefferi A (2007) JAK2 mutations in polycythemia vera – molecular mechanisms and clinical applications. N Engl J Med 356(5):444–445
Tefferi A (2007) Primary myelofibrosis and its paraneoplastic stromal effects. Haematologica 92(5):577–579
Shivakumar SP, Anderson DR, Couban S (2009) Catheter-associated thrombosis in patients with malignancy. J Clin Oncol 27(29):4858–4864
Lee AY et al (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349(2):146–153
Bates SM, Ginsberg JS (2004) Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med 351(3):268–277
Hebert PC et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340(6):409–417
Kuter DJ (2009) Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 60:193–206
Boccardo P, Remuzzi G, Galbusera M (2004) Platelet dysfunction in renal failure. Semin Thromb Hemost 30(5):579–589
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hough, B.O., Chatta, G.S. (2011). Hematological Changes, Anemia, and Bleeding in Older Persons. In: Rosenthal, R., Zenilman, M., Katlic, M. (eds) Principles and Practice of Geriatric Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6999-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6999-6_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6998-9
Online ISBN: 978-1-4419-6999-6
eBook Packages: MedicineMedicine (R0)